Product Information
NYSTATIN 100,000 UNIT/ML SUSP is a generic product labeled by PAI Holdings LLC, priced at $0.1442 per ML under NDC 00121086802. Its NADAC has been published 303 times since Sep 9, 2020.
Strength
100000 [USP'U]/mL
Manufacturer
PAI Holdings LLCNDC
00121086802
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
NYSTATINApproval Type
Generic (ANDA)
FDA Application
ANDA203621On Market Since
7/17/2020
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN 100,000 UNIT/ML SUSP has been published 303 times since Sep 9, 2020, and over the history we have for it it has declined 10.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1442 per ML |
|---|---|
| All-time high | $0.1741 (Nov 13, 2024) |
| All-time low | $0.0871 (Dec 21, 2022) |
| 52-week high | $0.1629 |
| 52-week low | $0.1383 |
| Median price | $0.1365 |
| Average price | $0.1317 |
| Largest weekly change | +34.7% (Mar 22, 2023) |
| Weeks tracked | 303 |
| Tracking since | Sep 9, 2020 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 61% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of NYSTATIN 100,000 UNIT/ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN 100,000 UNIT/ML SUSP, manufactured by PAI Holdings LLC, is $0.1442 per ML (NDC 00121086802), effective Jun 24, 2026.
How has the price of NYSTATIN 100,000 UNIT/ML SUSP changed over time?
Over the history we have for it, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has declined 10.2%. It has been tracked across 303 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for NYSTATIN 100,000 UNIT/ML SUSP?
Since Sep 9, 2020, the NADAC for NYSTATIN 100,000 UNIT/ML SUSP has ranged from a low of $0.0871 (Dec 21, 2022) to a high of $0.1741 (Nov 13, 2024), with a median of $0.1365 per ML.
Are there cheaper alternatives to NYSTATIN 100,000 UNIT/ML SUSP?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, NYSTATIN 100,000 UNIT/ML SUSP, is $0.0561 per ML — about 61% below NYSTATIN 100,000 UNIT/ML SUSP.
Who manufactures NYSTATIN 100,000 UNIT/ML SUSP?
NYSTATIN 100,000 UNIT/ML SUSP (NDC 00121086802) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification